No abstract available
MeSH terms
-
Animals
-
Antibodies / chemistry
-
Antibodies / therapeutic use
-
Antigen-Antibody Reactions
-
Chelating Agents / chemistry*
-
Copper Radioisotopes / chemistry*
-
Cyclotrons
-
Half-Life
-
Heterocyclic Compounds / chemical synthesis
-
Heterocyclic Compounds / chemistry
-
Heterocyclic Compounds, 1-Ring / chemistry
-
Humans
-
Immunoconjugates / chemistry
-
Immunoconjugates / pharmacokinetics
-
Immunoconjugates / therapeutic use
-
Nickel / chemistry
-
Nuclear Medicine
-
Organometallic Compounds / chemical synthesis
-
Organometallic Compounds / chemistry
-
Peptides / chemistry
-
Peptides / therapeutic use
-
Radioligand Assay
-
Radiopharmaceuticals / chemical synthesis*
-
Radiopharmaceuticals / therapeutic use
-
Somatostatin / analogs & derivatives
-
Somatostatin / chemistry
-
Tissue Distribution
-
Tomography, Emission-Computed
Substances
-
Antibodies
-
Chelating Agents
-
Copper Radioisotopes
-
Heterocyclic Compounds
-
Heterocyclic Compounds, 1-Ring
-
Immunoconjugates
-
Organometallic Compounds
-
Peptides
-
Radiopharmaceuticals
-
copper(II)-1,4,8,11-tetraazacyclotetradecane-N,N',N'',N'''-tetraacetic acid
-
1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid
-
Somatostatin
-
Nickel